We've captured, for the first time, live footage of Plasmodium falciparum microgametes actively "seeking" macrogametes, from in vitro cultures. A leap forward in understanding malaria transmission!

In New Orleans, Louisiana, US, in November 2024, at the American Society of Tropical Medicine and Hygiene (ASTMH) annual conference, Dr. Marion Avril, PI and Program Director at MalarVx, presented a poster regarding our cultured in vitro sporozoites research project. Then, Zach MacMillen, Res Sc I, presented a poster on our cGMP manufacturing of repRNA-based CSP malaria vaccine project. We were inspired by groundbreaking science from across the globe and thrilled to build valuable new connections.

Marion Avril of MalarVx, Inc. joins TWiP to discuss an accelerated prime-and-trap regimen using repRNA-based circumsporozoite vaccine.

In 2023, Dr. Marion Avril, the Principal Scientist and Program Director at MalarVx, presented a poster at the American Society of Tropical Medicine and Hygiene (ASTMH) annual conference. This session highlighted recent advancements in their vaccine research and development efforts aimed at eradicating malaria globally.

MalarVx Inc. participated in the 2022 American Society of Tropical Medicine and Hygiene (ASTMH) international conference.

MalarVx Inc. participated remotely at the virtual 2021 American Society of Tropical Medicine and Hygiene (ASTMH) international conference.